Quick Answer
Arcus Biosciences, Inc. reported Common Stock Shares Outstanding of 125.30 million shares for the year ending 2025.
- Arcus Biosciences, Inc. showed an increase of +35.9% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Arcus Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: 44.45 million shares | Q2 2018: 44.46 million shares | Q3 2018: 44.45 million shares | Q1 2019: 44.53 million shares | Q2 2019: 45.85 million shares | Q3 2019: 45.84 million shares | Q1 2020: 45.98 million shares | Q2 2020: 58.94 million shares | Q3 2020: 64.92 million shares | Q1 2021: 70.97 million shares | Q2 2021: 71.37 million shares | Q3 2021: 70.24 million shares | Q1 2022: 71.62 million shares | Q2 2022: 72.09 million shares | Q3 2022: 72.35 million shares | Q1 2023: 73.10 million shares | Q2 2023: 74.50 million shares | Q3 2023: 74.80 million shares | Q1 2024: 90.90 million shares | Q2 2024: 91.30 million shares | Q3 2024: 91.50 million shares | Q1 2025: 105.90 million shares | Q2 2025: 106.40 million shares | Q3 2025: 107.10 million shares.
- Over the full 9 years of available data (2017 to 2025), Arcus Biosciences, Inc.'s Common Stock Shares Outstanding has grown by 2,962.9%.
- Historical annual values: Fiscal year 2025: 125.30 million shares | Fiscal year 2024: 92.20 million shares | Fiscal year 2023: 75.50 million shares | Fiscal year 2022: 72.90 million shares | Fiscal year 2021: 70.80 million shares | Fiscal year 2020: 65.11 million shares | Fiscal year 2019: 45.93 million shares | Fiscal year 2018: 44.54 million shares | Fiscal year 2017: 4.09 million shares.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: